Related Experiment Video
Updated: Jul 14, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Community Pharmacist Perspectives on Observing and Dispensing Methadone for Opioid Use Disorder: Cross-sectional
Objectives:
To document community pharmacists' perceptions of the acceptability, appropriateness, and feasibility of dispensing methadone and observing methadone doses; willingness to dispense and observe doses; and perceived benefits, barriers, and negative consequences of methadone dispensing.
Methods:
A convenience sample of community pharmacists completed a cross-sectional survey from February to April 2025 that assessed pharmacists' perceived acceptability, appropriateness, and feasibility of observing methadone doses and dispensing methadone on a 5-point scale, with 3 being a neutral midpoint. T tests compared unadjusted scores, and linear regressions assessed whether pharmacist role, years in practice, pharmacy type, and rurality were associated with scores. Descriptive statistics were calculated for newly developed measures of willingness, benefits, barriers, and negative consequences of methadone dispensing.
Results:
The response rate was 21.9% (n=875). Pharmacists' mean acceptability, appropriateness, and feasibility scores were slightly negative to neutral, ranging from 2.75 to 3.10. Scores were significantly lower for observed dosing compared with dispensing. Urban pharmacists, independent pharmacists, pharmacy owners, and pharmacists newer to practice had more positive acceptability, appropriateness, and feasibility perceptions. Most pharmacists (71.7%) were willing to dispense take-home doses weekly; 48.6% were willing to observe doses daily. However, logistical barriers related to time and staffing and negative attitudes towards patients with opioid use disorder were also reported.
Conclusions:
Despite slightly negative to neutral perceptions of acceptability, appropriateness, and feasibility, many pharmacists are willing to implement methadone services, particularly dispensing take-home doses. Workflow integration tools and stigma reduction training may be needed to support implementation of pharmacy-based methadone services in the future.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Abuse and Addiction: Pharmacological Phenomena
Therapeutic Drug Monitoring: Affecting Factors
Opioid Analgesics: Morphine and Other Natural Cogeners
Therapeutic Drug Monitoring: Drug Analysis Methods
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...